×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CTNM – contineum therapeutics, inc. - common stock (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CTNM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/16
04:19 pm
ctnm
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791 [Yahoo! Finance]
Medium
Report
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791 [Yahoo! Finance]
12/16
04:05 pm
ctnm
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
Low
Report
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
11/25
08:05 am
ctnm
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
Medium
Report
Contineum Therapeutics to Attend the 7th Annual Evercore HealthCONx Conference
11/18
08:08 am
ctnm
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain [Yahoo! Finance]
Medium
Report
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain [Yahoo! Finance]
11/18
08:05 am
ctnm
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
Medium
Report
Contineum Therapeutics Expands Clinical Development of PIPE-791 With FDA Authorization of Its Investigational New Drug (IND) Application for Chronic Pain
11/13
04:05 pm
ctnm
Contineum Therapeutics to Attend Upcoming Investor Conferences
Medium
Report
Contineum Therapeutics to Attend Upcoming Investor Conferences
11/7
12:32 pm
ctnm
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $31.00. They now have an "outperform" rating on the stock.
Medium
Report
Contineum Therapeutics, Inc. (NASDAQ: CTNM) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $31.00. They now have an "outperform" rating on the stock.
11/6
05:06 pm
ctnm
Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Medium
Report
Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
8/13/2024
04:00 pm
ctnm
contineum therapeutics, inc. - common stock
MISS
Report
6.2%
contineum therapeutics, inc. - common stock
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/27
05:07 pm
ctnm
Form 4 Contineum Therapeutics, For: Nov 25 Filed by: Lorrain Daniel S.
Low
Report
Form 4 Contineum Therapeutics, For: Nov 25 Filed by: Lorrain Daniel S.
11/20
05:07 pm
ctnm
Form 4 Contineum Therapeutics, For: Nov 18 Filed by: Lorrain Daniel S.
Medium
Report
Form 4 Contineum Therapeutics, For: Nov 18 Filed by: Lorrain Daniel S.
11/18
05:06 pm
ctnm
Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
High
Report
Form 144 Contineum Therapeutics, Filed by: Lorrain Daniel S.
11/14
04:38 pm
ctnm
Form SC 13G Contineum Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
Medium
Report
Form SC 13G Contineum Therapeutics, Filed by: SECTORAL ASSET MANAGEMENT INC
11/6
04:11 pm
ctnm
Form 10-Q Contineum Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Contineum Therapeutics, For: Sep 30
11/6
04:09 pm
ctnm
Form 8-K Contineum Therapeutics, For: Nov 06
Medium
Report
Form 8-K Contineum Therapeutics, For: Nov 06
10/31
12:47 pm
ctnm
Form SCHEDULE 13G Contineum Therapeutics, Filed by: FRANKLIN RESOURCES INC
Low
Report
Form SCHEDULE 13G Contineum Therapeutics, Filed by: FRANKLIN RESOURCES INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: